Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-05-013631
Filing Date
2005-07-05
Accepted
2005-07-05 13:18:54
Documents
1
Period of Report
2005-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 2211
  Complete submission text file 0001179110-05-013631.txt   4085
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114 2062817001
NEORX CORP (Issuer) CIK: 0000755806 (see all company filings)

EIN.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O CELLEGY PHARMACEUTICALS INC 349 OYSTER POINT BLVD #200 S. SAN FRANCISCO CA 94080
Business Address 6506162200
KARLIN DAVID A (Reporting) CIK: 0001247409 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-16614 | Film No.: 05935793